Rein Therapeutics Inc. has entered into a Pre-Paid Advance Agreement $(PPA)$ with YA II PN, Ltd. (Yorkville), a Cayman Islands-based investment fund. Under the terms of the agreement, Rein Therapeutics may request pre-paid advances of up to $6.0 million from Yorkville over a 12-month period, with each advance purchased at 95% of its face value. The advances accrue interest at an annual rate of 8%, increasing to 18% in the event of default, and are due for repayment 12 months after issuance. On October 23, 2025, Rein Therapeutics received its third pre-paid advance of $1.0 million from Yorkville, netting $950,000 in proceeds. The transaction was conducted as a private placement under an exemption from SEC registration.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rein Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-250175), on October 24, 2025, and is solely responsible for the information contained therein.